Korian's Q3 Revenue Shows Steady Growth

Korian reported a revenue of €4,051 million for the first nine months of 2026, reflecting a 4.7% organic growth from the previous year. This growth is attributed to positive effects in volume, price, and case mix across all regions. The company reported an increase in the average occupancy rate of its medicalized nursing homes to 92.2%, from 90.8% in 2025.

The company also successfully refinanced €2.3 billion of debt, securing 92% at fixed rates, and received a B2 stable outlook rating from Moody's. In addition, Korian integrated the training division of Fondation Œuvre Croix Saint-Simon to bolster Clariane University’s offerings for nurses and care assistants in France.

CEO Sophie Boissard expressed confidence in sustaining the achieved momentum, highlighting the effectiveness of their financial restructuring and strong operational metrics. The company reaffirmed its financial objectives for both 2023-2026 and 2025-2028 periods.